Hollysys CEO Informs Company of Recent Share Sales
Hollysys Automation Technologies (NASDAQ: HOLI) announced that its CEO, Dr. Changli Wang, has sold a portion of his shares for personal financial planning.
Dr. Wang retains approximately 80% of his pre-sale holdings and has no plans for additional sales before the closing of a going-private transaction with Ascendent Capital Partners (ACP).
Management, including Dr. Wang, remains committed to meeting the closing conditions of the merger agreement with ACP.
- Dr. Changli Wang retains 80% of his pre-sale holdings, showing confidence in the company's future.
- The sale was for personal financial planning and does not affect operational plans.
- Commitment from management to meet closing conditions for the going-private transaction with ACP indicates stability.
- CEO share sale might signal to some investors a lack of confidence or potential concerns.
- No detailed financial figures provided to assess the impact on stock performance.
- Potential uncertainties until the going-private transaction is satisfactorily closed.
Expects to maintain majority of his holdings in the Company in anticipation of the going private transaction closing
Dr. Wang has informed the Company that following the sale, he holds approximately
The Company's management, including Dr. Wang, is committed to work towards the satisfaction of the closing conditions of the going private transaction by the parties in accordance with the merger agreement.
About Hollysys Automation Technologies Ltd.
Hollysys is a leading automation control system solutions provider in
Safe Harbor Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are "forward-looking statements," including statements regarding the ability of the Company to achieve its commercial objectives; the business strategy, plans and objectives of the Company; growth in financial and operational performance of the Company; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," or similar expressions involve known and unknown risks and uncertainties. Such forward-looking statements, based upon the current beliefs and expectations of Hollysys' management, are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
Contact Information
Company Contact:
Hollysys Automation Technologies Ltd.
www.hollysys.com
+8610-5898-1386
investors@hollysys.com
Media Contacts (
Brunswick Group
hollysys@brunswickgroup.com
Daniel Del Re (
ddelre@brunswickgroup.com
+852 9255 5136
Libby Lloyd (
llloyd@brunswickgroup.com
+1 347 283 3871
View original content:https://www.prnewswire.com/news-releases/hollysys-ceo-informs-company-of-recent-share-sales-302152855.html
SOURCE Hollysys Automation Technologies Ltd
FAQ
Why did Hollysys CEO Dr. Changli Wang sell shares?
What percentage of his holdings does Dr. Changli Wang retain after the sale?
Will Dr. Changli Wang sell more shares before the going-private transaction?
How does Dr. Wang's share sale affect Hollysys' going-private transaction?